Group 1:CAR-T

3 trials

Sponsors

Peking University Shougang Hospital, Cancer Hospital Affiliated to Guangxi Medical University, The First Affiliated Hospital, Zhejiang University School of Medicine

Conditions

Acute Myeloid LeukemiaColorectal cancerRelapsed or Refractory Multiple Myeloma

Early Phase 1

The Safety and Efficacy of SKB394-B Therapy in Relapsed or Refractory Multiple Myeloma

Active, not recruitingChiCTR2100054012

Cancer Hospital Affiliated to Guangxi Medical UniversityRelapsed or Refractory Multiple Myeloma

Start: 2021-12-13Updated: 2022-11-07

Phase 1

A Single-arm, Dose-escalation and Dose-expansion Phase I Clinical Study to Evaluate the Tolerability, Safety and Preliminary efficacy of BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Active, not recruitingChiCTR2300076953

The First Affiliated Hospital, Zhejiang University School of MedicineAcute Myeloid Leukemia

Start: 2023-10-26Updated: 2023-10-30

Phase 2

A phase I/II study for the tolerance, safety, cell kinetics and efficiency of immunotherapy in patients With stage III/IV colorectal cancer

RecruitingChiCTR1900024824

Peking University Shougang HospitalColorectal cancer

Start: 2019-07-29Updated: 2019-08-27